BUTINEURON

Active Principle: GABA-Pyridoxine ClH.
Therapeutic Effect: Normalizer of cerebral metabolism – Cerebrotonic.
Composition: Each tablet contains Gamma Amino Butyric Acid (GABA) 500 mg, Pyridoxine Hydrochloride 50 mg. Butineuron Syrup: Each 100 ml of syrup contains Gamma Amino Butyric Acid (GABA) 20 g, Pyridoxine Hydrochloride 2 g. Injectable Butineuron: Each 10 ml of injectable solution contains Gamma Amino Butyric Acid (GABA) 650 mg, Pyridoxal Phosphate 50 mg.
Presentation: Tablets: Packages containing 20, 50, 100 (EH), 500 (EH) and 1000 (EH) tablets. Syrup: Containers containing 60 ml, 120 ml and 200 ml. Injectable: Package containing 2, 5 and 10 ampoules of 10 ml and 20 ml